Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients.
Pogosova-Agadjanyan EL, Hua X, Othus M, Appelbaum FR, Chauncey TR, Erba HP, Fitzgibbon MP, Jenkins IC, Fang M, Lee SC, Moseley A, Naru J, Radich JP, Smith JL, Willborg BE, Willman CL, Wu F, Meshinchi S, Stirewalt DL.
Pogosova-Agadjanyan EL, et al. Among authors: stirewalt dl.
Biomark Res. 2023 Mar 16;11(1):31. doi: 10.1186/s40364-023-00461-0.
Biomark Res. 2023.
PMID: 36927800
Free PMC article.